Please assess the completion status of the following clinical trial:

Trial Title: Fenofibrate Therapy in Pathological Unconjugated Hyperbilirubinemia in Full Term Infants

Study Design Characteristics:
- Allocation: N/A
- Intervention Model: N/A
- Observational Model: N/A
- Primary Purpose: N/A
- Time Perspective: N/A
- Masking: N/A
- Phase: None
- Number of Arms: 3.0

Eligibility Criteria:
Inclusion Criteria:~* we included appropriate for gestational age full-term infants with pathological unconjugated hyperbilirubinemia who are candidate for phototherapy according to American academy of pediatrics guidelines~Exclusion Criteria:~* Full term infants with intrauterine growth restriction, congenital malformations, conjugated hyperbilirubinemia, severe jaundice initially required exchange transfusion, skin abrasions or infection, and preterm infants were excluded

- Gender: ALL
- Minimum Age: None
- Maximum Age: 28 Days
- Healthy Volunteers: None

Study Arms:
- GROUP1 (Type: ACTIVE_COMPARATOR): group receiving single dose fenofibrate
- GROUP2 (Type: ACTIVE_COMPARATOR): group receiving double dose fenofibrate
- GROUP3 (Type: PLACEBO_COMPARATOR): photo therapy only

Based on this trial design, predict the completion outcome and termination type (if applicable).